Maxygen Buying Back Stock; Analysts Say No Trend Here Nov. 16, 2009 By Trista Morrison Maxygen Inc. on Friday became the latest member of a very small biotech cadre that is returning cash to shareholders. (BioWorld Today) Read More
NewCo News: Kalos Hits Financing Trail for Peptide-Based MAPK Inhibitor Nov. 5, 2009 By Trista Morrison
